Implementation and validation of a combined MRI-CT-based cervical cancer brachytherapy program using existing
Theodora A Koulis1, Corinne M Doll1, Derek Brown2
1Department of Oncology, University of Calgary, Calgary, AB, Canada; Division of Radiation Oncology, Tom Baker Cancer Centre, Calgary, AB, Canada.
Brachytherapy
|May 25, 2016
Summary
Implementing an MRI-CT-based cervical cancer brachytherapy program is feasible using existing infrastructure. This approach ensures treatment plans meet GEC-ESTRO recommendations for target coverage and organ-at-risk constraints.
Area of Science:
- Oncology
- Radiotherapy
- Medical Imaging
Background:
- Cervical cancer brachytherapy (BT) planning traditionally relies on Point A.
- Three-dimensional (3D) imaging, particularly MRI, offers improved visualization of tumors and organs at risk (OARs).
- Integrating MRI-CT into BT planning can enhance treatment precision.
Purpose of the Study:
- To describe the implementation of an MRI-CT-based cervical cancer brachytherapy program.
- To evaluate the impact of this integrated approach on treatment planning and adherence to guidelines.
Main Methods:
- A step-wise implementation using a process map and prospective risk analysis.
- Review of patient charts (January 2013-December 2014) with MRI during BT planning.
- Dosimetric comparison between traditional Point A and 3D-based prescriptions, and between MRI-planned and CT-planned treatments.
Main Results:
- The MRI-CT planning program was successfully implemented using existing infrastructure.
- Eighty percent of treatments were prescribed to a point other than Point A.
- Plans met GEC-ESTRO recommendations for high-risk clinical target volume coverage and OAR dose constraints, with no major differences between MRI-planned and CT-planned (with MRI guidance) treatments.
Conclusions:
- An MRI-CT-based cervical cancer brachytherapy planning program is feasible with existing resources.
- The implemented program ensures treatment plans adhere to GEC-ESTRO guidelines, optimizing patient care.


